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Abstract
Introduction: It has been proposed that intensive care unit (ICU)-acquired weakness (ICUAW) should be assessed
using the sum of manual muscle strength test scores in 12 muscle groups (the sum score). This approach has been
tested in patients with Guillain-Barré syndrome, yet little is known about the feasibility or test characteristics in
other critically ill patients. We studied the feasibility and interobserver agreement of this sum score in a mixed
cohort of critically ill and injured patients.
Methods: We enrolled patients requiring more than 3 days of mechanical ventilation. Two observers performed
systematic strength assessments of each patient. The primary outcome measure was interobserver agreement of
weakness as a binary outcome (ICUAW is sum score less than 48; “no ICUAW” is a sum score greater than or equal
to 48) using the Cohen’s kappa statistic.
Results: We identified 135 patients who met the inclusion criteria. Most were precluded from study participation
by altered mental status or polytrauma. Thirty-four participants were enrolled, and 30 of these individuals
completed assessments conducted by both observers. Six met the criteria for ICUAW recorded by at least one
observer. The observers agreed on the diagnosis of ICUAW for 93% of participants (Cohen’s kappa = 0.76; 95%
confidence interval (CI), 0.44 to 1.0). Observer agreement was fair in the ICU (Cohen’s kappa = 0.38), and
agreement was perfect after ICU discharge (Cohen’s kappa = 1.0). Absolute values of sum scores were similar
between observers (intraclass correlation coefficient 0.83; 95% CI, 0.67 to 0.91), but they differed between observers
by six points or more for 23% of the participants.
Conclusions: Manual muscle testing (MMT) during critical illness was not possible for most patients because of
coma, delirium and/or injury. Among patients who were able to participate in testing, we found that interobserver
agreement regarding ICUAW was good, particularly when evaluated after ICU discharge. MMT is insufficient for
early detection of ICU-acquired neuromuscular dysfunction in most patients and may be unreliable during critical
illness.
Introduction
Patients with acute respiratory failure, shock and other
manifestations of critical illness or injury are at risk of
developing neuromuscular dysfunction as a result of
entities such as critical illness polyneuropathy, critical
illness myopathy and disuse atrophy [1-3]. Many of
these patients have severe weakness which is detectable
on the basis of a clinical strength evaluation. This severe
weakness has been termed “i n t e n s i v ec a r eu n i t - a c q u i r e d
paresis” [4] or ICU-acquired weakness (ICUAW) [5].
This condition is diagnosed on the basis of the average
Medical Research Council (MRC) strength score com-
b i n e df o r1 2s p e c i f i e dm u s c l eg r o u p s( t h eM R Cs u m
score) being less than 48, indicating that average
strength is limited to movement against gravity and par-
tial resistance [6]. Observational studies have reported
that ICUAW is common, with an incidence of 25%
[4,7], and is associated with poor outcomes, including
mortality [7], prolonged mechanical ventilation [4,7,8]
and the need for additional institutional care after hospi-
tal discharge [7].
Systematic strength assessment and the definition of
ICUAW according to the MRC sum score is becoming
more common in research [9] and has been recommended
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is known about the feasibility or test characteristics of
manual muscle testing (MMT) or about ICUAW as a
dichotomous diagnosis on the basis of the MRC sum
score for the general population of patients with critical ill-
ness. There are two groups for whom studies of interob-
server agreement of MRC sum scores have been
described: patients with Guillain-Barré syndrome [6] and
ICU survivors after hospital discharge [10]. Compared
with these groups, ICU general population patients are
less likely to be able to cooperate with volitional strength
assessment and more likely to have limited access to their
extremities because of trauma, burns and treatment invol-
ving medical devices. We sought to determine the feasibil-
ity of assessment and interobserver agreement regarding
the diagnosis of ICUAW and the MRC sum score in a
mixed cohort of critically ill and injured patients.
Materials and methods
Study design
We conducted a prospective study of critically ill
patients at a single academic county hospital in Seattle,
WA, USA, during 4 months in 2006 and 2007. We
obtained approval from the institutional review board of
the University of Washington for all study procedures.
Screening and eligibility
Critically ill patients were consecutively screened for
eligibility after 48 hours in the ICU. Inclusion criteria
included age at least 18 years, at least 3 days of mechan-
ical ventilation for acute respiratory failure and the
expectation that the patient would be able to follow
complex commands. We excluded patients with spinal
cord injury, stroke, injury preventing the evaluation of
six or more muscle groups, inability to follow complex
commands during the follow-up period, inability to
understand English and inability to provide informed
consent.
Study procedures
Eligible patients were screened 5 days each week for
attention and comprehension on the basis of their
responses to five orders as described by De Jonghe et al.
[4]. Screening was coordinated with daily interruption of
sedation according to institutional protocol. Once the
patient was able to follow at least three orders consis-
tently, two observers performed the structured MMT:
BKL, a senior medical resident, and CLH, an attending
critical care physician. Prior to this study, both observers
completed multistep training in performance of MMT
that included the creation of a detailed MMT instruc-
tion manual, didactic teaching of each other and other
healthcare professionals and supervised practice in and
out of the ICU setting (with a standardized patient as
well as practice patients in the ICU). The order of
observer assessment was random (determined by coin
flip). Examinations were performed independently
within 30 minutes of each other. The second observer
was blinded to the results of the first observer’s
evaluation.
Each observer repeated the attention screen and then
performed the 12 muscle group strength assessment:
bilateral shoulder abduction, elbow flexion, wrist exten-
sion, hip flexion, knee extension and foot dorsiflexion.
The patient was positioned in either the sitting or
supine position, depending on the patient’sc l i n i c a l
situation. Strength in each muscle group was scored
according to the six-point MRC system, in which a
score of 0 was no contraction, 1 was a flicker of con-
traction, 2 was active movement with gravity eliminated,
3 was active movement against gravity, 4 was active
movement against gravity and resistance and 5 was nor-
mal power [11]. If the patient would not or could not
perform the test for an individual muscle group, no
score was recorded and data were indicated as missing.
Data collection and statistical analyses
We collected demographic and hospital variables from
electronic medical records. Admission diagnoses and
ICU complications (the presence of ventilator-associated
pneumonia, sepsis, acute respiratory distress syndrome,
bacteremia, renal failure or Clostridium difficile colitis)
were abstracted from hospital discharge summaries. We
calculated statistics (means ± standard deviation (SD),
medians with interquartile range (IQR) and proportion
or binomial confidence interval (CI)) to describe the
cohort. We calculated one MRC sum score for each
observer per patient. If the patient was unable to per-
f o r mat e s tf o ram u s c l eg r o u p ,w ea s s i g n e dt h es c o r e
on the basis of the score for the contralateral joint; if
unavailable, we used the score for the ipsilateral group
of muscles in the same proximity (hip: shoulder, knee:
elbow or wrist: foot). ICUAW was defined as a MRC
sum score less than 48.
We calculated the primary outcome measure, interob-
server agreement on ICUAW, on the basis of the simple
Cohen’s kappa statistic [12] and the 95% confidence
interval [13]. The strength ratings may be unbalanced or
skewed, so the prevalence and bias-adjusted Cohen’s
kappa statistics [14,15] are also presented. We calculated
the proportion of positive (p-pos) and the proportion of
negative (p-neg) agreement between observers regarding
the diagnosis of ICUAW [16]. We performed a sensitiv-
ity analysis of the effect of assigning scores on the basis
of the score for the contralateral joint or for the ipsilat-
eral group of muscles by restricting our primary analysis
to patients who performed the MMT with all 12 muscle
groups. We then stratified the cohort by the location of
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lated the agreement in each group. Agreement was
graded on a scale of “poor” to “almost perfect” as sug-
gested by Landis and Koch [17]. Using the methodology
described by Kleyweg et al. [6], we calculated the pro-
portion of patients for whom the observers’ sum scores
differed by 10% or more (more than six points). Since
the two raters were considered a random sample of the
population of possible raters, intraclass correlation coef-
ficients were computed on the basis of two-way random
effects models for absolute agreement [15,18]. We also
looked at the absolute agreement for each individual
muscle group with the weighted Cohen’s kappa statistic,
comparing each observer’s MRC score as an ordered
categorical variable (scores from 0 to 5). Statistical cal-
culations were performed using Stata version 10.0 soft-
ware (College Station, TX, USA) and SAS version 9.2
software (SAS Institute Inc., Cary, NC, USA).
Results
A flowchart of patient screening and enrollment is pre-
sented in Figure 1. Of the 135 patients who met the
inclusion criteria, nearly half did not pass the attention
screen during the study period (n = 62; 46%). Thirty-
four patients (25% of eligible patients) consented to par-
ticipate in the study. These 34 patients’ baseline charac-
teristics are presented in Table 1.
Patients received a median of 10 days of mechanical
ventilation before the study examination (IQR, 6 to 16
days). Among patients who failed to pass the attention
screen, more than 1 week elapsed in most cases between
the identification of an eligible patient and performance
of the examination (median, 8 days; IQR, 6 to 12 days).
Thirty patients were able to perform MMT administered
by both observers (88%). One died before the examina-
tion, one refused to participate and two were unable to
complete the assessment because of issues related to
attention and pain control. Although all patients were
initially identified in the ICU, only 10 examinations
occurred in the ICU; the remaining 20 took place after
ICU discharge to the hospital ward. Only two patients
were receiving mechanical ventilation at the time of
examination. Most patients who performed the MMT
were tested in all muscle groups (n = 17; 57%). Eleven
patients were tested in 10 or 11 muscle groups, and two
patients were tested in seven or eight muscle groups.
Table 2 presents the number of patients in whom each
muscle group was assessed by both observers. We were
135patientsmetinclusion
criteria
34subjectsenrolled
30patientscompleted
assessment
Excluded(101)
Ͳ 62Inattention
Ͳ 15Injuryto> 6musclegroups
Ͳ 10NonͲEnglishspeaking
Ͳ 10Declinedparticipation
Ͳ 2Prisoners
Ͳ 2NoLegalnextofkin
Unabletocompleteassessment(4)
Ͳ 2Restrictedbypain
Ͳ 1Died
Ͳ 1Refusedtocooperate
Figure 1 Flowchart showing screening, enrollment and evaluation.
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of injury, pain and the presence of medical devices
(such as casts, external fixation devices and extensive
burn dressings).
The median MRC sum scores for each observer were
55 (IQR, 49 to 58) and 56 (IQR, 50 to 58). The continu-
ous outcome of the MRC sum score differed by 10% or
more between observers for 7 (23%) of the 30 patients.
The intraclass correlation coefficient of the sum score
was 0.83 (95% CI, 0.67 to 0.93). As shown in Table 2,
the agreement of the scores for individual muscle
groups was poor, particularly among the more proximal
muscles. Agreement ranged from 40% to 83%, the
weighted Cohen’s kappa statistics ranged from 0.11 to
0.64 and the interclass correlation coefficients ranged
from 0.15 to 0.75.
Each observer identified six patients with ICUAW
(MRC sum score <48), with an incidence of 17% (95%
CI, 3% to 31%). Among all patients, the interobserver
agreement was 93% (Cohen’s kappa = 0.76; 95% CI, 0.44
to 1.0). The prevalence and bias-adjusted Cohen’sk a p p a
was 0.87. p-pos agreement was 80%, and p-neg agree-
ment was 96%. Assignment of missing values did not
change the estimates of agreement. After stratifying the
sample on the basis of the hospital location of examina-
tion, we found that both cases in which the observers
disagreed occurred in the ICU. Agreement on the diag-
nosis of ICUAW was poor for patients examined in the
I C U :O b s e r v e r sa g r e e d8 0 %o ft h et i m e( C o h e n ’sk a p p a
= 0.38). Agreement regarding ICUAW on the hospital
ward was 100% (Cohen’s kappa = 1.0). Although not
statistically significant, patients evaluated in the ICU
were less likely than those on the hospital ward to per-
form complete examinations (40% versus 65%; P = 0.20).
Discussion
In our cohort of critically ill surgical and medical
patients, we found that systematic MMT could not be
performed in the ICU for most patients. MMT requires
the attention and comprehension of the patient; thus
t h eh i g hp r e v a l e n c eo fp e r s i s t e n tc o m aa n dd e l i r i u mi n
our population prohibited evaluation. While our institu-
tion has a sedation protocol with daily interruption of
sedation, it is very likely that a more conservative least
sedation [19,20] or no sedation [21] approach could
have markedly decreased the number of delirious and
Table 1 Patient demographics
a
Demographic variable Data
Age, yr (mean ± SD) 49 ± 15
Male sex, % 71%
Admission service
Surgery, % 53%
Medical, % 32%
Neurology/neurosurgery, % 15%
Admission diagnosis
b
Trauma, % 44%
Infection, % 29%
Other, % 27%
Any ICU complications
c, % 62%
Median days of mechanical ventilation
prior to examination (interquartile range)
10 days (6 to 16)
Median days between eligibility and
examination (interquartile range)
8 days (6 to 12)
aICU, intensive care unit;
b“Other” admission diagnoses include chronic
obstructive pulmonary disease exacerbation, congestive heart failure, variceal
or subarachnoid hemorrhage, burns, drowning and alcoholic hepatitis;
cICU
complications include ventilator-associated pneumonia, sepsis, renal failure,
bacteremia, Clostridium difficile colitis and acute respiratory distress syndrome.
Table 2 Interobserver agreement regarding MRC score: individual muscle groups
a
Muscle mobility Number Average of exams Median
(IQR)
Agreement,
%
Weighted kappa (95%
CI)
b
Intraclass correlation coefficient (2, 1)
(95% CI)
c
Shoulder
abduction: R
28 4.5 (4 to 5) 57% 0.51 (0.32 to 0.71) 0.68 (0.43 to 0.83)
Shoulder
abduction: L
27 4.5 (3.5 to 4.5) 47% 0.36 (0.12 to 0.60) 0.53 (0.21 to 0.75)
Elbow flexion: R 29 4.5 (4 to 5) 57% 0.35 (0.08 to 0.62) 0.53 (0.21 to 0.74)
Elbow flexion: L 29 4.5 (4.5 to 5) 60% 0.23 (0 to 0.55) 0.29 (0 to 0.59)
Wrist extension: R 28 5 (4.5 to 5) 80% 0.56 (0.30 to 0.82) 0.61 (0.32 to 0.79)
Wrist extension: L 30 4.5 (4.5 to 5) 73% 0.44 (0.16 to 0.73) 0.50 (0.18 to 0.72)
Hip flexion: R 26 4 (3.5 to 5) 53% 0.47 (0.25 to 0.70) 0.62 (0.33 to 0.80)
Hip flexion: L 24 4.25 (3.5 to 5) 40% 0.32 (0.11 to 0.53) 0.50 (0.17 to 0.73)
Knee extension: R 28 4.75 (4.25 to 5) 60% 0.29 (0.02 to 0.57) 0.31 (0 to 0.59)
Knee extension: L 28 4.75 (4.5 to 5) 60% 0.29 (0.02 to 0.57) 0.31 (0 to 0.59)
Foot dorsiflexion: R 26 5 (4.5 to 5) 80% 0.64 (0.43 to 0.85) 0.75 (0.54 to 0.87)
Foot dorsiflexion: L 28 5 (4.75 to 5) 40% 0.32 (0.11 to 0.53) 0.50 (0.17 to 0.73)
aR, right; L, left; IQR, interquartile range; CI, confidence interval; MRC, Medical Research Council;
bweighted kappa treating strength scale as ordinal linear weights;
ctwo-way random effects model (raters and participants treated as random effects) intraclass correlation coefficient treating strength scale as continuous.
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luation earlier in the course of the patients’ critical ill-
ness. Some patients were discharged from the hospital
before MMT could be performed, and others died
before assessment. In other patients, extensive injury
due to burns or other trauma prevented evaluation
because of generalized weakness. The investigators in
the two largest studies of interobserver agreement
regarding MMT in critically ill patients did not investi-
gate the ability of patients to cooperate with volitional
testing [6,10]; it appears that the only patients who were
included were able to fully participate in the study pro-
cedures. We expect that the issues of delirium, coma
and injury would have been uncommon among both
patients with Guillain-Barré syndrome patients and out-
patient survivors of critical illness.
Prospective studies of ICUAW have encountered pro-
blems with the feasibility of MMT in critically ill
patients. De Jonghe et al. [4] identified 332 critically ill
medical and surgical patients who met the inclusion
requirement of 7 or more days of mechanical ventila-
tion. One hundred one patients were excluded because
of neurologic disease, and 10 were excluded because of
language barriers or lack of assessable limbs. Of the 206
patients remaining, more than half (n = 111) did not
awaken often enough to be evaluated before discharge
or death. It is not clear whether most strength evalua-
tions were done in the ICU or on the ward in their
study, but the authors reported that the mean delay
between the onset of mechanical ventilation was 12.4
days (SD, 6.8 days). We can therefore infer that even
among the minority subset of eligible patients who had
been selected for their ability to cooperate with strength
testing, MMT was generally not performed early in the
course of their critical illness.
In a more recent study of medical ICU patients who
received 5 or more days of mechanical ventilation, Ali
et al. [7] enrolled 174 patients, and only 38 patients
(22%) were unable to perform the MMT. However,
94 patients were excluded because they were “unlikely
to awaken,” and 40 additional patients were excluded
because of inability to communicate. As such, 50% of
potential patients were not included because of cognitive
inability to cooperate with volitional testing. The
authors did not present data about patients’ location in
the ICU versus the hospital ward at the time of initial
evaluation. They reported that most patients were first
assessed on or after the day of the cessation of mechani-
cal ventilation (NA Ali, personal communication, April
2009). The Ali et al. [7] study included an assessment of
interobserver agreement between two observers who
examined 12 patients. They reported perfect agreement
regarding the diagnosis of ICUAW but did not present
the timing or location of these 12 evaluations.
In the current investigation, we found that interobser-
ver agreement regarding ICUAW was good among
patients who were able to participate in MMT, particu-
larly in those patients evaluated after ICU discharge.
The 95% CI of the Cohen’s kappa statistic is wide,
including both poor and almost perfect agreement, since
the incidence of ICUAW was low and our sample was
small. As such, we cannot be confident that interobser-
ver agreement is as excellent as previously reported, par-
ticularly for assessments performed in the ICU.
Interobserver agreement on the MRC sum score as a
continuous outcome was rarely perfect and differed by
10% or more for nearly one-fourth of patients. Interob-
server agreement for individual muscle groups was poor,
particularly for the proximal muscles. The proximal
muscles, especially the hip flexors, were the most likely
not to be assessed.
This study is limited by the small sample size and the
low incidence of ICUAW among the assessable patients.
The strengths of this study include the diverse popula-
tion of critically ill patients included and the focus on
feasibility as well as the reliability of strength testing in
the ICU. The intensive training in the performance the
MMT protocol likely decreased the variability between
observers, allowing this study to highlight the problems
of attention and consistent cooperation among critically
ill patients.
Our focus on the timing of the examination during
the course of critical illness adds to the current knowl-
edge about the feasibility of including MMT as part of a
research or clinical protocol for patients in the acute
p h a s eo fc r i t i c a li l l n e s s .I tm a yb et r u et h a t ,f o rm a n y
patients, identification of ICUAW before awakening
may not affect clinical care or outcome, particularly
among those who die in the ICU. However, earlier diag-
nosis may already inform the prognosis for and manage-
ment of individual patients, such as those requiring
prolonged mechanical ventilation or those with central
nervous system pathology [22], and will hopefully iden-
tify patients likely to benefit from future therapeutics.
Also important is that clinical, translational and basic
investigation of the incidence, mechanisms, treatments
and outcomes of neuromuscular dysfunction will clearly
benefit from a more inclusive approach to the identifica-
tion of ICUAW.
Conclusions
In conclusion, although MMT is feasible and reliable in
the outpatient setting [10,23,24] and in selected critically
ill patients without central nervous system dysfunction
[6], neither group is at risk for the acute brain dysfunc-
tion that affects most patients during critical illness [25]
and precludes early participation in volitional testing.
For the subset of critically ill patients who can be
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regarding the diagnosis of ICUAW is good, particularly
when performed after ICU discharge. However, as ICU
clinicians and researchers, we cannot be satisfied with
restricting our assessment of patients for neuromuscular
dysfunction to those who can participate in the exami-
nation. Since ICU-acquired neuromuscular dysfunction
(including critical illness polyneuropathy and myopathy)
is likely associated with severity of illness [4] and may
even share the same pathogenesis as septic encephalopa-
thy and acute brain dysfunction [26,27], the patients
who cannot be assessed are the most likely to be
affected by it.
The ability to detect these physical functional abnorm-
alities early in the course of critical illness is crucial to
understanding their incidence and biology, improving
prognostication, guiding care, and administering and
monitoring interventions designed to prevent or limit the
development of ICU-acquired neuromuscular dysfunc-
tion. As such, we need to continue to develop and test
alternative approaches to the diagnosis of ICU-acquired
neuromuscular dysfunction, such as electrophysiologic
testing [28-30], nonvolitional strength measurement [31],
histology [22,32] and ultrasound [33]. We need to con-
tinue to perform MMT for all patients who are able to
cooperate, and we need to continue the hard work of
attempting to identify and minimize reversible causes of
delirium and coma in the ICU [20,34,35]. Interventions
such as early mobilization of ICU patients [36] are pro-
mising, potentially offering treatments that can decrease
delirium, increase patients’ ability to cooperate with
MMT and decrease ICUAW at the same time.
Key messages
￿ Recognition of ICUAW is important.
￿ Although standardized assessment of ICU patients
for weakness using MMT has been proposed, little is
known about the feasibility or reliability of this
approach.
￿ We found that most ICU patients cannot partici-
pate in MMT during acute critical illness or injury.
￿ Although we could not assess many critically ill
patients with MMT in the ICU, feasibility and inter-
observer agreement improved after patients’ transfer
to the hospital ward.
￿ Nonvolitional approaches to neuromuscular assess-
ment may be important to advance early recognition
and potential treatment of ICUAW.
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